Antimicrobial resistance surveillance in Europe 2014
Antimicrobial resistance surveillance in Europe 2014
English (7.29 MB - PDF)* Only data from isolates tested against all five antimicrobial groups were included in the analysis.
Number of laboratories reporting isolates resistant to third-generation cephalosporins (3GCREC), numbers of 3GCREC isolates identified and percentage of isolates positive for extended-spectrum beta-lactamase (ESBL), as ascertained by the participating laboratories, EU/EEA countries, 2014
Number of laboratories reporting isolates resistant to third-generation cephalosporins (3GCREC), numbers of 3GCREC isolates identified and percentage of isolates positive for extended-spectrum beta-lactamase (ESBL), as ascertained by the participating laboratories, EU/EEA countries, 2014
* Not adjusted for population differences in reporting countries
Number of laboratories reporting isolates resistant to third generation cephalosporins (3GCRKP), numbers of 3GCRKP isolates identified and percentage of isolates positive for extended-spectrum beta-lactamase (ESBL), as ascertained by the participating laboratories, EU/EEA countries, 2014
Number of laboratories reporting isolates resistant to third generation cephalosporins (3GCRKP), numbers of 3GCRKP isolates identified and percentage of isolates positive for extended-spectrum beta-lactamase (ESBL), as ascertained by the participating laboratories, EU/EEA countries, 2014
Total number of invasive isolates tested (N) with combined resistance (resistance to three or more antimicrobial groups among piperacillin(+tazobactam), ceftazidime, fluoroquinolones, aminoglycosides and carbapenems) including 95% confidence intervals (95% CI), by country, EU/EEA countries, 2011-2014
Total number of invasive isolates tested (N) with combined resistance (resistance to three or more antimicrobial groups among piperacillin(+tazobactam), ceftazidime, fluoroquinolones, aminoglycosides and carbapenems) including 95% confidence intervals (95% CI), by country, EU/EEA countries, 2011-2014
Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Total number of invasive isolates tested (N) and percentage resistant to ceftazidime (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Total number of invasive isolates tested (N) and percentage resistant to ceftazidime (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2011-2014
Total number of invasive isolates tested (N) and percentage resistant to piperacillin+tazobactam (%R
Total number of invasive isolates tested (N) and percentage resistant to piperacillin+tazobactam (%R), including 95% confidence intervals (95%CI), EU/EEA countries, 2011-2014
Total number of invasive isolates tested (N) and percentage resistant to piperacillin+tazobactam (%R), including 95% confidence intervals (95%CI), EU/EEA countries, 2011-2014
Total number of tested isolates and resistance combinations among invasive isolates tested against at least three antimicrobial groups among piperacillin±tazobactam, ceftazidime, fluoroquinolones, aminoglycosides and carbapenems (n=11 649 ), EU/EEA countries, 2014
Total number of tested isolates and resistance combinations among invasive isolates tested against at least three antimicrobial groups among piperacillin±tazobactam, ceftazidime, fluoroquinolones, aminoglycosides and carbapenems (n=11 649 ), EU/EEA countries, 2014
Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2012-2014
Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2012-2014
Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2012-2013
Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2012-2013
Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2012-2014
Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2012-2014
Share this page